
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Intrinsic Value
The intrinsic value of one
Jiangsu Hengrui Pharmaceuticals Co Ltd
stock under the Base Case scenario is
38.21
CNY.
Compared to the current market price of 52.81 CNY,
Jiangsu Hengrui Pharmaceuticals Co Ltd
is
Overvalued by 28%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Jiangsu Hengrui Pharmaceuticals Co Ltd
Fundamental Analysis



Revenue & Expenses Breakdown
Jiangsu Hengrui Pharmaceuticals Co Ltd
Balance Sheet Decomposition
Jiangsu Hengrui Pharmaceuticals Co Ltd
Current Assets | 35.3B |
Cash & Short-Term Investments | 25.1B |
Receivables | 6.4B |
Other Current Assets | 3.8B |
Non-Current Assets | 14.8B |
Long-Term Investments | 1.7B |
PP&E | 7.4B |
Intangibles | 5B |
Other Non-Current Assets | 651.8m |
Free Cash Flow Analysis
Jiangsu Hengrui Pharmaceuticals Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Jiangsu Hengrui Pharmaceuticals Co Ltd
Revenue
|
29.2B
CNY
|
Cost of Revenue
|
-4.2B
CNY
|
Gross Profit
|
25B
CNY
|
Operating Expenses
|
-17.6B
CNY
|
Operating Income
|
7.3B
CNY
|
Other Expenses
|
-504.5m
CNY
|
Net Income
|
6.8B
CNY
|
Profitability Score
Profitability Due Diligence
Jiangsu Hengrui Pharmaceuticals Co Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Score
Jiangsu Hengrui Pharmaceuticals Co Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Jiangsu Hengrui Pharmaceuticals Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Score
Jiangsu Hengrui Pharmaceuticals Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Jiangsu Hengrui Pharmaceuticals Co Ltd
According to Wall Street analysts, the average 1-year price target for
Jiangsu Hengrui Pharmaceuticals Co Ltd
is 59.16 CNY
with a low forecast of 45.96 CNY and a high forecast of 84 CNY.
Dividends
Current shareholder yield for Jiangsu Hengrui Pharmaceuticals Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Jiangsu Hengrui Pharmaceuticals Co Ltd
stock under the Base Case scenario is
38.21
CNY.
Compared to the current market price of 52.81 CNY,
Jiangsu Hengrui Pharmaceuticals Co Ltd
is
Overvalued by 28%.